Kukje Pharma Co., Ltd. (002720.XKRX) Dividend Analysis
Does Kukje Pharma Co. (002720.XKRX) pay a dividend?
Yes. Kukje Pharma Co. (002720.XKRX) pays a dividend: KRW 30.00 per share over the last twelve months, a dividend yield of 0.73% at the latest close.
The payout takes about 10.5% of earnings.
Computed from company filings. Ex-dividend and payment dates are not part of those filings, so they are not shown here. This is analysis, not investment advice.
| Fiscal year | Per share | Change |
|---|---|---|
| 2025 | KRW 30.00 | 0.0% |
| 2024 | KRW 30.00 |
All 2 fiscal years we hold. Each payment counts toward the fiscal year it is paid for, so a final dividend paid in spring belongs to the year before. Figures are adjusted for stock splits, so a fall is a cut.
FCF does not fully cover the dividend, sustainability is a concern, no sustained growth pattern yet.
Based on TTM and annual data · Not a buy/sell signal
Score Breakdown
Safety
40% of composite
Growth
35% of composite
Income
25% of composite
Composite = Safety (50) × 0.40 + Growth (0) × 0.35 + Income (25) × 0.25 = 26
Dividend Yield
0.73%
Per Share (TTM)
KRW 30.00
Payout Ratio
10.5%
1Y CAGR
0.0%
Dividend Safety
Earnings Payout
10.5%
FCF Payout
—
FCF Coverage
-1.9x
Dividend Growth
Per Share (TTM)
KRW 30.00
Growth Streak
—
1Y CAGR
0.0%
Dividend Income
Annual DPS (TTM)
KRW 30.00
Annual Income / KRW 10K
KRW 73
Payment frequency, ex-dividend and payment dates are not available from company filings. Check your broker or the company's investor relations page for the schedule.
Yield History
Kukje Pharma Co. (002720.XKRX) dividend: yield, safety and growth
Frequently asked
Does Kukje Pharma Co. (002720.XKRX) pay a dividend, and how much?+
Yes, Kukje Pharma Co. pays a regular dividend of about KRW 30.00 per share per year (a yield of roughly 0.7%). That is a payout ratio of about 10.5% of earnings, so it is not currently covered by free cash flow. A low headline yield is not the same as a weak dividend: what matters is how well earnings and cash flow cover the payout, not the percentage alone. The full payout history and per-share figures are on this dividends tab.
Is Kukje Pharma Co.'s dividend safe?+
Kukje Pharma Co.'s dividend looks not currently covered by free cash flow, with free cash flow covering the payout about -1.9 times over. Intrinsiqq scores its dividend safety at 50 out of 100, weighing the payout ratio, free-cash-flow coverage and balance-sheet strength. Safety matters more than yield: a payout you can rely on beats a high one you cannot.
Has Kukje Pharma Co. grown its dividend?+
Kukje Pharma Co.'s dividend history is mixed. Recent dividend growth has been roughly flat. Consistent growth is one of the strongest signals of a durable, shareholder-friendly business, so read the streak alongside coverage on this tab.
What is Kukje Pharma Co.'s dividend payout ratio?+
Kukje Pharma Co. pays out about 10.5% of its earnings as dividends. A lower payout ratio leaves more room to keep raising the dividend and to absorb a bad year, while a very high ratio can signal a payout under pressure. On this measure the dividend is not currently covered by free cash flow. See the dividend-safety breakdown for the free-cash-flow view, which is often more telling than earnings.
Related stocks: Drug Manufacturers - Specialty & Generic
Spot a number that looks wrong?
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.